文献速递肿瘤 PET/CT

比较[68Ga]Ga-FAP-2286 PET/CT与[18F]-FDG PET/CT在不同类型胸膜和腹膜转移瘤中的诊断价值

Comparison of the diagnostic value of [68Ga]Ga-FAP-2286 PET/CT and [18F]-FDG PET/CT imaging in different types of pleural and peritoneal metastatic tumors.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-04-24

该回顾性研究纳入2022年1月至2024年11月在本科室同时接受[18F]-FDG和[68Ga]Ga-FAP-2286 PET/CT检查的92例疑似胸膜/腹膜转移患者,比较两种显像的SUVmax、SUVpeak、TBR及灵敏度。[68Ga]Ga-FAP-2286 PET/CT的SUVmax、SUVpeak、TBR和灵敏度均高于[18F]-FDG PET/CT,尤其在腹膜转移、肝胆胰肿瘤、胃肠道肿瘤及腺癌中诊断价值更高。

要点

  • [68Ga]Ga-FAP-2286 PET/CT的SUVmax、SUVpeak、TBR及灵敏度均高于[18F]-FDG PET/CT。
  • 对腹膜转移,[68Ga]Ga-FAP-2286 PET/CT的SUVmax、SUVpeak、TBR均高于[18F]-FDG PET/CT。
  • 在肝胆胰肿瘤、胃肠道肿瘤及腺癌中,[68Ga]Ga-FAP-2286 PET/CT诊断价值更高。

核心结论

  • 对胸膜/腹膜转移,[68Ga]Ga-FAP-2286 PET/CT检出率高于[18F]-FDG PET/CT,诊断效能更好,尤其对腹膜转移。
  • 在各类肿瘤中,[68Ga]Ga-FAP-2286 PET/CT对肝胆胰肿瘤、胃肠道肿瘤及腺癌的诊断价值更高。

研究设计与样本

  • 回顾性分析2022年1月至2024年11月在本科室同时接受[18F]-FDG和[68Ga]Ga-FAP-2286 PET/CT检查的患者。
  • 共纳入92例疑似胸膜/腹膜转移患者,测量胸膜/腹膜转移灶的SUVmax、SUVpeak和TBR并比较两种显像。

主要发现

  • [68Ga]Ga-FAP-2286 PET/CT vs [18F]-FDG PET/CT:SUVmax 7.87 vs 6.28(P=0.002),SUVpeak 5.88 vs 4.65(P<0.001),TBR 6.27 vs 3.85(P<0.001),灵敏度95.3% vs 84.7%(P=0.035)。
  • 腹膜转移:[68Ga]Ga-FAP-2286 PET/CT vs [18F]-FDG PET/CT的SUVmax 8.25 vs 5.75(P<0.001),SUVpeak 6.18 vs 4.29(P<0.001),TBR 6.54 vs 3.50(P<0.001)。
  • 肝胆胰肿瘤:[68Ga]Ga-FAP-2286 PET/CT vs [18F]-FDG PET/CT的SUVmax 7.88 vs 6.02,SUVpeak 5.88 vs 4.33,TBR 6.15 vs 3.67。
  • 胃肠道肿瘤:[68Ga]Ga-FAP-2286 PET/CT vs [18F]-FDG PET/CT的SUVmax 8.27 vs 5.69,SUVpeak 6.28 vs 4.30,TBR 7.03 vs 3.50。
  • 腺癌:[68Ga]Ga-FAP-2286 PET/CT vs [18F]-FDG PET/CT的SUVmax 8.30 vs 5.80,SUVpeak 6.17 vs 4.30,TBR 6.60 vs 3.55。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the diagnostic value of [68Ga]Ga-FAP-2286 PET/CT and [18F]-FDG PET/CT imaging in different types of pleural/peritoneal metastatic tumors. METHODS: A retrospective analysis was conducted on patients who underwent both [18F]-FDG and [68Ga]Ga-FAP-2286 PET/CT in our department between January 2022 and November 2024. The maximum standardized uptake value (SUVmax), peak SUV (SUVpeak), and tumor-to-background ratio (TBR) of pleural/peritoneal metastatic lesions were measured, and the results obtained from the two imaging modalities were compared. RESULTS: A total of 92 patients suspected of having pleural/peritoneal metastases were included in the study. The [68Ga]Ga-FAP-2286 PET/CT showed higher SUVmax, SUVpeak, TBR, and sensitivity compared to [18F]-FDG PET/CT (7.87 vs. 6.28; P = 0.002; 5.88 vs. 4.65; P < 0.001; 6.27 vs. 3.85; P < 0.001; 95.3% vs. 84.7%; P = 0.035), especially for peritoneal metastases (8.25 vs. 5.75; P < 0.001; 6.18 vs. 4.29; P < 0.001; 6.54 vs. 3.50; P < 0.001). Among various tumors, [68Ga]Ga-FAP-2286 PET/CT showed better detection results for hepatobiliary and pancreatic tumors (7.88 vs. 6.02, 5.88 vs. 4.33, 6.15 vs. 3.67), gastrointestinal tumors (8.27 vs. 5.69, 6.28 vs. 4.30, 7.03 vs. 3.50), and adenocarcinomas (8.30 vs. 5.80, 6.17 vs. 4.30, 6.60 vs. 3.55). CONCLUSION: For pleural/peritoneal metastases, [68Ga]Ga-FAP-2286 PET/CT has a higher detection rate compared to [18F]-FDG PET/CT, providing better diagnostic efficacy, particularly for peritoneal metastases. Among various tumors, [68Ga]Ga-FAP-2286 PET/CT has higher diagnostic value in hepatobiliary and pancreatic tumors, gastrointestinal tumors, and adenocarcinomas.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Liu H, Wang J, Ji Y, et al. Comparison of the diagnostic value of [68Ga]Ga-FAP-2286 PET/CT and [18F]-FDG PET/CT imaging in different types of pleural and peritoneal metastatic tumors. Eur J Nucl Med Mol Imaging. 2025. PMID: 40272499. doi:10.1007/s00259-025-07265-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。